oa CSIR Science Scope - Drug discovery for diseases prevalent in Africa

Volume 2, Issue 1
  • ISSN :



A major shift in the biotechnology industry has biotechnology companies building small molecule or chemistry expertise and integrating this expertise with existing biology capability. The integration is providing a critical advantage in finding innovative new molecules for the treatment of diseases. In parallel with this shift, big pharmaceutical companies have been expanding into biologics, largely through acquisition of biotechnology companies.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error